From: Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model
Source
Countries
Denmark
Finland
Netherlands
Sweden
Kanavos et al. [6]
6–7%
3%
13–24%
2–3%
Carone et al. [15]a
6.5%
18%
2.5%
Swiss Regulation [14]
2.7%
Austrian Price Commission [13]
2.9%